Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.
Kvistborg P, Philips D, Kelderman S, Hageman L, Ottensmeier C, Joseph-Pietras D, Welters MJ, van der Burg S, Kapiteijn E, Michielin O, Romano E, Linnemann C, Speiser D, Blank C, Haanen JB, Schumacher TN.
Kvistborg P, et al. Among authors: michielin o.
Sci Transl Med. 2014 Sep 17;6(254):254ra128. doi: 10.1126/scitranslmed.3008918.
Sci Transl Med. 2014.
PMID: 25232180